Victoza Alternatives: GLP-1 Class Options and Compounded Paths
Looking beyond Victoza means understanding the GLP-1 class it belongs to. This guide maps how liraglutide and its neighbors work, their approved uses and side effects, the cost landscape, the compounded-pharmacy pathway, and the genetic architecture that stays constant across every alternative.
History of GLP-1 Drugs: Complete Timeline From Exenatide (2005) to Tirzepatide and Beyond
The complete history of GLP-1 drugs — from 1902 incretin research to exenatide (2005), Victoza (2010), Ozempic (2017), Rybelsus (2019), Wegovy (2021), Mounjaro (2022), Zepbound (2023), and pipeline candidates orforglipron — with where PlexusDx Semaglutide, Tirzepatide, Microdose, and GLP-Squared protocols fit in 2026.
